Location History:
- Zurich, CH (2016)
- Zürich, CH (2014 - 2022)
Company Filing History:
Years Active: 2014-2022
Title: The Innovative Contributions of Daniel Steiner in Recombinant Binding Proteins
Introduction
Daniel Steiner, an accomplished inventor based in Zurich, Switzerland, has made significant strides in the field of biotechnology. With a portfolio of seven patents, his work primarily revolves around the development of recombinant binding proteins and their applications in treating various diseases. His innovations have garnered attention for their potential therapeutic benefits.
Latest Patents
Steiner's latest patents include groundbreaking designs of ankyrin repeat domains with binding specificity for serum albumin. His contributions lay in the description of recombinant binding proteins that not only consist of at least two designed ankyrin repeat domains with specificity for serum albumin but also contain domains with binding specificity for hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF-A). These technologies encompass nucleic acids that encode such designed ankyrin repeat domains and pharmaceutical compositions that leverage these innovations for disease treatment. This dual approach enhances the therapeutic potential of his inventions, making them vital in the medical field.
Career Highlights
Throughout his career, Daniel Steiner has collaborated with leading organizations, like Molecular Partners AG and the University of Zurich. His work within these institutions has propelled advancements in biotechnology, specifically in the design and application of recombinant binding proteins. Steiner's expertise has been influential in transforming theoretical concepts into practical applications, which are now paving the way for novel treatment approaches.
Collaborations
In his journey, Steiner has worked alongside notable colleagues such as Patrik Forrer and Michael Tobias Stumpp. Their collaborations have enriched the research and development process, allowing for a cross-pollination of ideas and expertise, which is essential in the fast-evolving landscape of biotechnology.
Conclusion
Daniel Steiner's inventive spirit and dedication to enhancing medical treatments through recombinant binding proteins reflect the significant impact an inventor can have on society. With multiple patents to his name and continued efforts in research and development, his contributions to biotechnology are likely to influence future innovations and improvements in therapeutic applications. As the field advances, Steiner's work will undoubtedly remain at the forefront of innovation.